Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIA 28-6156 drug-drug interaction study with levodopa/carbidopa or levodopa/benserazide
NL-OMON50655Active, not recruiting
- Sponsor
- BIAL
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pariceract in Parkinson's disease (PD) (2 arms), sponsored by BIAL. Started Nov 2021; status: active, not recruiting.
02
Drugs
pariceract
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON50655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50655.